文献速递静脉血栓栓塞慢性静脉疾病

FlowTriever与ClotTriever系统治疗下腔静脉血栓的疗效评估

Management of inferior vena cava thrombosis with the FlowTriever and ClotTriever systems.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-10-10

本研究为多中心回顾性病例系列,纳入15例下腔静脉血栓患者,采用ClotTriever和/或FlowTriever系统行机械取栓。技术成功13例,无溶栓治疗、无出血事件、无ICU入住;随访中所有技术成功患者无症状且无下腔静脉再闭塞。

要点

  • 机械取栓治疗下腔静脉血栓技术成功率高,本组15例中13例成功。
  • 无患者需要辅助溶栓治疗,无术后出血事件及ICU入住。
  • 技术成功患者随访均无症状且无下腔静脉再闭塞。

核心结论

  • ClotTriever和FlowTriever系统在不使用纤溶药物的情况下治疗下腔静脉血栓显示出应用前景,无出血事件且无需ICU停留。

主要发现

  • 15例患者中男性10例,平均年龄59岁;14例有症状,13例有深静脉血栓病史,8例有下腔静脉滤器。
  • 技术成功13例;2例失败分别因非闭塞性血栓紧密附着于下腔静脉滤器和慢性橡胶样血栓无法清除。
  • 无患者需要伴随溶栓治疗或术后入住ICU;无术后出血事件、心肌梗死、肺栓塞、肾损伤或死亡;中位住院时间3天(范围1-37天)。
  • 术后随访7例,延长随访(>6个月)8例;所有技术成功患者无症状,随访影像无下腔静脉再闭塞证据。

临床怎么用

  • 对于下腔静脉血栓,可考虑使用ClotTriever和/或FlowTriever系统进行机械取栓,避免纤溶药物相关出血风险。
  • 术前应评估血栓特征(如是否附着于滤器或慢性机化),以预测技术成功率。

局限性

  • 回顾性研究,样本量小(15例),随访不完整(术后随访仅7例,延长随访8例)。
  • 设备选择由术者决定,存在选择偏倚;缺乏对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although inferior vena cava (IVC) thrombosis is infrequently encountered, it carries a significant risk of post-thrombotic syndrome and pulmonary embolus. Recent studies show no difference in the incidence of post-thrombotic syndrome in patients with iliofemoral deep venous thrombosis (DVT) treated with pharmacothrombolysis vs anticoagulation alone; however, there is an associated increased risk of bleeding. The treatment of IVC thrombosis is less well-studied and the hemodynamic changes may be more significant with pharmacothrombolysis, although the bleeding risk remains. The ClotTriever and FlowTriever systems remove thrombus from veins without the use of thrombolytics. Our study evaluates outcomes of patients undergoing mechanical thrombectomy for the treatment of IVC thrombosis using the ClotTriever and FlowTriever devices. METHODS: A retrospective chart review was performed to identify consecutive patients who underwent mechanical thrombectomy for the treatment of IVC thrombosis using the ClotTriever and/or FlowTriever systems from November 2018 to January 2020 at four data-sharing institutions. The decision of which device(s) to use was at the discretion of the surgeon. Patient demographics, symptomatology, and imaging characteristics were captured at presentation and follow-up. RESULTS: A total of 15 patients met the inclusion criteria; 10 were male, and the average age was 59 years. The majority of patients were symptomatic at presentation (n = 14), had a prior history of DVT (n = 13), and had a preexisting IVC filter (n = 8). Eleven patients presented with acute onset (<1 week) of symptoms, whereas three patients had subacute (1-4 weeks) symptoms. Most patients had an associated iliofemoral DVT (n = 13) and were treated with both ClotTriever and FlowTriever (n = 8); others were treated with either ClotTriever or FlowTriever alone (n = 5 and n = 2, respectively). Technical success was achieved in all but two patients, one who had a nonocclusive thrombus densely adherent to a preexisting IVC filter and another who had a chronic rubbery clot in the IVC that could not be cleared. No patient required concomitant lytic therapy or a postoperative stay in the intensive care unit. Furthermore, there were no postoperative bleeding events, myocardial infarctions, pulmonary emboli, renal impairments, or deaths. The median length of stay was 3 days (range, 1-37 days). Patients underwent postoperative follow-up (n = 7) as well as extended follow-up (>6 months; n = 8). All patients who achieved technical success were asymptomatic without evidence of reocclusion of the IVC on follow-up imaging. CONCLUSIONS: In our multicenter series of 15 patients, The ClotTriever and FlowTriever showed promise in the treatment of IVC thrombosis without the use of fibrinolytic drugs, with no bleeding events and no requirement for intensive care unit stay.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Shah NG, Wible BC, Paulisin JA, et al. Management of inferior vena cava thrombosis with the FlowTriever and ClotTriever systems. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33045392. doi:10.1016/j.jvsv.2020.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。